Search

Introduction: Peripheral atherosclerotic disease (PAD) is a condition characterized by low functional capacity which is associated with impaired free living, ambulation and low exercise tolerance. The purpose of this randomized controlled study was to evaluate whether changes in maximal walking time are associated with adaptations in cardiovascular function following supervised exercise. Methods: After ethics approval, 28 patients (63 ± 11 years) completed a graded treadmill test (2 min stages, 3·2 km h−1, with gradient increasing 2% every 2 min) until they reached level three or four on the claudication pain scale. Peak oxygen consumption was assessed on a breath-by-breath basis, by online expiratory gas analysis. Following a 40-min recovery period, peak cardiac output was measured using the non-invasive carbon dioxide rebreathing method described by Defares ( J Appl Physiol, 13, 1958, 159). Peak cardiac power output was then computed using the equation described by Cooke et al. ( Heart, 1998, 79, 289). Patients were randomly assigned to one of two groups: supervised, who exercised at the hospital twice weekly for 12 weeks or control, who received normal treatment which included encouragement to walk regularly. Results: After 12 weeks, there were no significant changes in body mass, peak oxygen consumption, peak cardiac output, peak heart rate, peak cardiac power output, respiratory exchange ratio or rating of perceived exertion in both the supervised and control group. There was a significant improvement (91%) in maximal walking distance following the supervised exercise programme. Although patients’ peak cardiovascular measurements were unchanged, the patients in the supervised exercise group were able to complete a higher workload at the end of the 12 weeks of exercise, for the equivalent demands on the circulation system. Conclusions: The findings from this study suggest that a short-term period of supervised exercise training results in an improved walking time in patients with limiting claudication because of PAD. It also demonstrated that the cardiovascular system becomes more efficient in meeting the demands of exercise. It is recommended that individuals with PAD should undertake exercise as a form of treatment. [ABSTRACT FROM AUTHOR]

Introduction: Peripheral vascular disease (PVD) is a condition characterized by atherosclerotic occlusive disease of the lower extremities, low functional capacity and low exercise tolerance. Less empirical data are available concerning the cardiovascular response to maximum exercise tests in patients with PVD. The purpose of this study was to examine cardiovascular variables in patients with peripheral vascular disease. Methods: Fifty patients (67 ± 9 years) completed an incremental exercise test (2 min stages, 3·2 km h−1, with increases of 2% every 2 min) to maximum claudication pain. Maximal oxygen consumption ( ) was assessed on a breath-by-breath basis by online expiratory gas analysis (CardiO2, Medical Graphics Co.). Blood pressure was recorded at peak exercise. Following a 30-min rest period, patients exercised at the highest level attained during the first test and cardiac output ( ) was measured using the exponential non-invasive rebreathing method. Cardiac power output peak (CPOpeak) in Watts (W), was then computed. Results: Mean ± SD values were; 13·85 ± 4·14 ml kg min−1; maximal walk time 357 ± 227 s; peak mean arterial pressure 127 ± 15 mmHg; 9·8 ± 2·39 (l min−1); CPO 2·86 ± 0·87 W. Conclusion: Patients with peripheral vascular disease demonstrate attenuated levels of cardiovascular capacity. This group of patients should be given exercise therapy in order to improve cardiovascular status and ambulatory function. [ABSTRACT FROM AUTHOR]

Automated metabolic gas analysis systems have advanced considerably over the past decade. They provide an abundance of information, which is not possible by using the traditional Douglas bag method and have become an essential tool in both physiological monitoring and in the diagnosis of cardiopulmonary disease. The validity and reliability of the different online metabolic analyzer systems are not well known, with relatively few independent studies being published. The purpose of this review was to examine and evaluate current literature regarding the validity and reliability of commercially available metabolic analyzer systems. This review reveals significant differences between the available systems in the way that they capture and process basic respiratory measurements. Online metabolic analyzer systems were found to vary significantly when compared with Douglas bag methods. These variations have the potential to introduce error into the accuracy with which the health of cardiovascular system can be assessed or training loads can be assigned. Compounding this is the fact that many automated systems are a “black box”, which makes it easy to generate data without the user having much understanding of how the data were generated. In conclusion automated metabolic analyser systems are a scientifically robust method for the evaluation of cardiopulmonary function. Individual researchers and clinicians must, however, be able to make their own decisions about the level of error that is tolerable for their individual needs. This presents a significant practical challenge in light of the speed with which technical developments in the field occur and we make some suggestions for the formulation of intersystem comparison studies. [ABSTRACT FROM AUTHOR]